tiprankstipranks
Trending News
More News >
Bright Minds Biosciences (DRUG)
NASDAQ:DRUG
US Market

Bright Minds Biosciences (DRUG) Technical Analysis

Compare
274 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Bright Minds Biosciences’s (DRUG) Moving Averages Convergence Divergence (MACD) indicator is 0.08, suggesting Bright Minds Biosciences is a Sell.
Bright Minds Biosciences’s (DRUG) 20-Day exponential moving average is 81.10, while Bright Minds Biosciences’s (DRUG) share price is $85.48, making it a Buy.
Bright Minds Biosciences’s (DRUG) 50-Day exponential moving average is 79.32, while Bright Minds Biosciences’s (DRUG) share price is $85.48, making it a Buy.

Bright Minds Biosciences (DRUG) Pivot Points

Feb 23, 2026, 04:14 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
71.99
74.99
80.54
83.54
89.09
92.09
97.64
Fibonacci
74.99
78.26
80.28
83.54
86.81
88.83
92.09
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bright Minds Biosciences (DRUG) Moving Averages

Feb 23, 2026, 04:14 AM
Period
Simple
Exponential
MA5
82.73Buy
83.17Buy
MA10
79.79Buy
81.44Buy
MA20
80.02Buy
81.10Buy
MA50
83.34Buy
79.32Buy
MA100
72.31Buy
72.03Buy
MA200
53.45Buy
57.56Buy
Bright Minds Biosciences’s (DRUG) 10-Day exponential moving average is 81.44, while Bright Minds Biosciences’s (DRUG) share price is $85.48, making it a Buy.
Bright Minds Biosciences’s (DRUG) 100-Day exponential moving average is 72.03, while Bright Minds Biosciences’s (DRUG) share price is $85.48, making it a Buy.
Bright Minds Biosciences’s (DRUG) stock price is $85.48 and Bright Minds Biosciences’s (DRUG) 50-day simple moving average is 83.34, creating a Buy signal.
Bright Minds Biosciences’s (DRUG) stock price is $85.48 and Bright Minds Biosciences’s (DRUG) 100-day simple moving average is 72.31, creating a Buy signal.
Bright Minds Biosciences’s (DRUG) stock price is $85.48 and Bright Minds Biosciences’s (DRUG) 200-day simple moving average is 53.45, creating a Buy signal.

Bright Minds Biosciences (DRUG) Technical Indicators

Feb 23, 2026, 04:14 AM
Name
Value
Implied Action
RSI (14)
55.84
Neutral
STOCH (9,6)
81.83
Sell
STOCHRSI (14)
82.49
Sell
MACD (12,26)
0.08
Sell
ADX (14)
23.06
Neutral
Williams %R
-14.65
Sell
CCI (14)
102.27
Sell
ATR (14)
6.16
-
Ultimate Oscillator
62.33
Neutral
ROC
9.94
Buy
Bright Minds Biosciences’s (DRUG) Relative Strength Index (RSI) is 55.84, creating a Neutral signal.
Bright Minds Biosciences’s (DRUG) Trend Strength Indicator (ADX) is 23.06, creating a Neutral signal.
Bright Minds Biosciences’s (DRUG) Commodity Channel Index (CCI) is 102.27, creating a Sell signal.
Bright Minds Biosciences’s (DRUG) Price Rate of Change (ROC) is 9.94, creating a Buy signal.

FAQ

Is DRUG a Buy, Hold, or Sell?
Based on DRUG’s technical indicators, DRUG is a Buy.
    What is DRUG’s RSI (14)?
    DRUG’s RSI (14) is 55.84, which suggests DRUG is a Neutral.
      What is DRUG’s MACD?
      DRUG’s MACD is 0.08, which suggests DRUG is a Sell.
        What is DRUG’s 5-day moving average?
        DRUG’s 5-day moving average is 82.73, which suggests DRUG is a Buy.
          What is DRUG’s 20-day moving average?
          DRUG 20-day moving average is 80.02, which suggests DRUG is a Buy.
            What is DRUG’s 50-day moving average?
            DRUG’s 50-day moving average is 83.34, which suggests DRUG is a Buy.
              What is DRUG’s 200-day moving average?
              DRUG’s 200-day moving average is 53.45, which suggests DRUG is a Buy.
                What is DRUG’s Williams % R (14)?
                DRUG’s Williams % R (14) is -14.65, which suggests DRUG is a Sell.
                  What is DRUG’s CCI (14)?
                  DRUG’s CCI (14) is 102.27, which suggests DRUG is a Sell.